Companies: 10,795·Total market cap: $144.5T
HH Biotechnology Holdings Company

HH Biotechnology Holdings Company

HHBTOTCReal Estate● Active
$0.00
+$0.00(+0.00%)
Market Cap$1406
P/E Ratio
52W High$0.0002
52W Low$0.0001

HH Biotechnology Holdings Company (HHBT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

hhbt · pe ratio · data through Dec 31, 2015

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for HH Biotechnology Holdings Company (HHBT) measures how much investors pay for each dollar of the company's trailing earnings. HHBT's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.18. −100.0% discount vs 5Y avg 17.7x

0.00x
P/E Ratio (TTM)100.0%

Source: FMP · /ratios-ttm · /analyst-estimates · 2015-12-31

Forward P/E
N/A
EPS (TTM)
$0.18
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HH Biotechnology Holdings Company SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2015 – 2015 · Annual
PE Ratio (TTM)
5Y Avg 17.7x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Real Estate - Services · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
HH Biotechnology Holdings Company
HH Biotechnology Holdings CompanyYou
HHBT
$0M0.00x$0.18
AmeriCann, Inc.
AmeriCann, Inc.
ACAN
$0MN/A-$0.05
Agritek Holdings, Inc.
Agritek Holdings, Inc.
AGTK
$0MN/A-$0.57
Bresler & Reiner, Inc.
Bresler & Reiner, Inc.
BRER
$0MN/A-$3.92
Canal Capital Corporation PFD EXCH $1.30
Canal Capital Corporation PFD EXCH $1.30
COWPP
$0MN/A$0.00
Vert Infrastructure Ltd.
Vert Infrastructure Ltd.
CRXPF
$0MN/A-$0.14
China Evergrande Group
China Evergrande Group
EGRNF
$1MN/A-$8.02

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 1 of 1 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2015-12-31Latest
FY2015
17.74x$0.18

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for HH Biotechnology Holdings Company (HHBT) measures how much investors pay for each dollar of the company's trailing earnings. HHBT's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.18.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ $0.18 = 0.00x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

HHBT pe ratio · 6 questions

HHBT's current PE ratio is 0.00x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.18. Data sourced from Financial Modeling Prep via HHBT's SEC 10-K and 10-Q filings.

HHBT PE ratioWhat is HHBT PE ratioCurrent PE ratio of HHBTHHBT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · HH Biotechnology Holdings Company SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09